ET-1 expression and growth inhibition of prostate cancer cells: A retinoid target with novel specificity

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4817-4822

  Hsu, Ju Yu ^a   Pfahl, Magnus ^a,b  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b MAXIA Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)BENZO[B]THIOPHENE 6 CARBOXYLIC ACID; 4 [1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CYCLOPROPYL]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; CD 2809; CD 436; ENDOTHELIN 1; RETINOIC ACID; RETINOID; SR 11220; SR 11238; SR 11256; SR 11302; TAMIBAROTENE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

DNA-BINDING PROTEINS; ENDOTHELIN-1; GATA2 TRANSCRIPTION FACTOR; HUMANS; MALE; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RETINOIDS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032211274     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-111, 1994.
2. de Vos, S., Dawson, M. I., Holden, S., Le, T., Wang, A., Cho, S. K., Chen, D-L., and Koeffler, H. P. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells. Prostate, 32: 115-121, 1997.
3. Pfahl, M., Apfel, R., Bendik, I., Fanjul, A., Graupner. G., Lee, M-O., La-Vista, N., Lu, X-P., Piedrafita, J., Ortiz Caseda, A., Salbert, G., and Zhang, X-K. Nuclear retinoid receptors and their mechanism of action. Vitam. Horm., 49: 327-382, 1994.
4. 1. Endocrinology 138: 1491-1497, 1997.
5. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.), 332: 411-415, 1988.
6. Baley, P. A., Resink, T. J., Eppenberger, U., and Hahn, A. W. Endothelin messenger RNA and receptors are differentially expressed in cultured human breast epithelial and stromal cells. J. Clin. Invest., 85: 1320-1323, 1990.
7. Shichiri, M., Hirata, Y., Nakajuma, T., Ando, K., Imai, T., Yanagisawa, M., Masaki, T., and Marumo, F. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. Clin. Invest., 87: 1867-1871, 1991.
8. Oikawa, T., Kushuhara, M., Ishikawa, S., Hitomi, J., Kono, A., Iwanaga, T., and Yamaguchi, K. Production of endothelin-1 and throbomodulin by pancreatic cancer cells. Br. J. Cancer, 69: 1059-1064, 1994.
9. Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., and Simons, J. W. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med., 1: 944-949, 1995.
10. Nelson, J. B., Chan-Tack, K., Hedican, S. P., Magnuson, S. R., Opgenorth, T. J., Bova, G. S., and Simons, J. W. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res., 56: 663-668, 1996.
11. Dorfman, D. M., Wilson, D. B., Bruns, G, A., and Orkin, S. H. Human transcription factor GATA-2. Evidence of regulation of preproendothelin-1 gene expression in endothelial cells. J. Biol. Chem., 267: 1279-1285, 1992.
12. Bailly, J., Delescluse, C., Bernardon, J. M., Charpentier, B., Martin, B., Pilgrim, W. R., Shroot, B., and Darmon, M. Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptors. Skin Pharmacol., 3: 256-267, 1990.
13. Dawson, M. I., Jong, I. L., Hobbs, P. D., Cameron, J. F., Chao, W-R., Pfahl, M., Lee, M-O., Shroot, B., and Pfahl, M. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem., 38: 3368-3383, 1995.
14. Kizaki, M., Dawson, M. I., Heyman, R., Elstner, E., Morosetti, R., Pakkala, S., Chen, D-L., Ueno, H., Chao, W-R., Morikawa, M., Ikeda, Y., Heber, D., Pfahl, M., and Koeffler. H. P. Effects of novel retinoid X receptor-selective ligands on myeloid leukemic differentiation and proliferation in vitro. Blood, 5: 1977-1984, 1996.
15. Reichert, U., Bernardo, J. M., Charpentier, B., Nedoncelle, P., Martin, B., Bernard, B. A., Asselineau, D., Michel, S., Lenoir, M. C., Delescluse, C., Pilgrim, W. R., Darmon, Y. M., and Shroot, B. Synthetic retinoids: receptor selectivity and biological activity. Mol. Biol. Therapeut. Pharmacol. Skin Besel, Karger, 5: 117-127, 1993.
16. Dawson, M. I., Chao, W-R., Pine, P., Jong, L., Hobbs, P. C., Rudd, C. K., Quick, T. C., Niles, R. M., Zhang, X-K., Lombardo, A., Ely, K. R., Shroot, B., and Fontana, J. A. Correlation of retinoid binding affinity to retinoic acid receptor α with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res., 55: 4446-4451, 1995.
17. Kawana, M., Lee, M., Quertermous, E. E., and Quertermous, T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol. Cell. Biol., 15: 4225-4231, 1995.
18. Zhou, M-D., Sucov, H. M., Evans, R. M., and Chien, K. R. Retinoid-dependent pathways suppress myocardial cell hypertrophy. Proc. Natl. Acad. Sci. USA, 92: 7391-7395, 1995.
19. Lu, X-P., Fanjul, A., Picard, N., Pfahl, M., Rungta, D., Nared-Hood, K., Carter, B., Piedrafita, F. J., Tang, S., Fabbrizio, E., and Pfahl, M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med., 3: 686-690, 1997.
20. Lee, M. E., Dhadly, M. S., Temizer, D. H., Clifford, J. A., Yoshizumi, M., and Quertermous, T. Regulation of endothelin-1 gene expression by Fos and Jun. J. Biol. Chem., 266: 19034-19039, 1991.
21. Webber, M. M., Bello, D., and Quader, S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 1. Cell markers and immortalized nontumorigenic cell lines. Prostate, 29: 386-394, 1996.
22. Webber, M. M., Bello, D., and Quader, S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate, 30: 58-64, 1997.
23. Benatti, L., Bonecchi, L., Cozzi, L., and Sarmientos, P. Two preproendothelin 1 mRNAs transcribed by alternative promoters. J. Clin. Invest., 91: 1149-1156, 1993.
24. Arendt, R. M., Lampen, L. W., Heucke, L., Suhler, K., Ritter, M., and Richter, W. O. Ir-ET circulates in human plasma: elevated concentrations in patients with hyperlipoproteinemia. Am. J. Hypertens., 3: 93A, 1990.
25. Kahaleh, M. B. Endothelin: an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum., 34: 978-983, 1991.